Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases

Lodewijka H.J. Holtkamp, Annette H. Chakera, Sebastian Fung, Jonathan R. Stretch, Robyn P.M. Saw, Kenneth Lee, Sydney Ch'Ng, Maria Gonzalez, John F. Thompson, Louise Emmett, Omgo E. Nieweg

Research output: Contribution to journalArticlepeer-review

8 Citations (Web of Science)


Whole-body positron emission tomography/computed tomography (PET/CT) and brain magnetic resonance imaging (MRI) are commonly used to stage patients with palpable lymph node metastases from melanoma, but their role in patients with satellite and/or in-transit metastasis (S&ITM) is unclear. The aim of this study was to establish the diagnostic value of PET/CT and brain MRI in these patients, and to assess their influence on subsequent management decisions. In this prospective study, 25 melanoma patients with a first presentation of S&ITM who had no clinical evidence of palpable nodal or distant metastasis underwent whole-body 18F-FDG PET/CT and brain MRI after a tentative pre-scan treatment plan had been made. Sensitivity and specificity of imaging were determined by pathological confirmation, clinical outcome and repeat PET/CT and MRI at 6 months. PET/CT led to a modification of the initial treatment plan in four patients (16%). All four were upstaged (AJCC stage eighth edition). PET/CT was false-positive in one patient, who had a Schwannoma in his trapezius muscle. A thyroid carcinoma was an incidental finding in another patient. The sensitivity of PET/CT was 58% and specificity 83%. In 6 months following the baseline PET/CT, further sites of in-transit or systemic disease were identified in 10 patients (40%). Brain MRI did not alter the treatment plan or change the disease stage in any patient. Whole-body PET/CT improved staging in melanoma patients with S&ITM and changed the originally-contemplated treatment plan in 16%. MRI of the brain appeared not to be useful.

Original languageEnglish
Pages (from-to)358-363
Number of pages6
JournalMelanoma Research
Issue number4
Publication statusE-pub ahead of print - Aug 2020
Externally publishedYes


Dive into the research topics of 'Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases'. Together they form a unique fingerprint.

Cite this